Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 12/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.58 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.58 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.58 |
| ▸ | CCR2 | P41597 | 1/20 | 0.58 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL725147 | 0.90 | SIGMAR1 (0.66) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| Hydrochloric Acid SCHEMBL28689372 | 0.88 | CXCR4 (0.66) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL31341381 | 0.84 | CXCR4 (0.58) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL2006300 | 0.83 | CXCR4 (0.77) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL1259387 | 0.82 | CXCR4 (0.81) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| Bromide SCHEMBL1257550 | 0.80 | CXCR4 (0.78) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL1244075 | 0.80 | ALDH1A1 (0.73) | HRH3SIGMAR1ALDH1A1KDM4ELMNA | |
| SCHEMBL17224097 | 0.80 | SIGMAR1 (0.79) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| Hydrochloric Acid SCHEMBL5573232 | 0.78 | CXCR4 (0.78) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL2236508 | 0.78 | LTA4H (0.49) | CXCR4MEN1CHRM2CHRM1ADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122228-A1 | METAL-ORGANIC COORDINATION COMPOUND COMPRISING CERIUM(III) | BEEOLED GMBH (DE) | 2025-04-17 | — | — | US | disclosed |
| EP-4323365-A1 | METAL-ORGANIC COORDINATION COMPOUND COMPRISING CERIUM(III) | beeOLED GmbH (DE) | 2024-02-21 | — | — | EP | disclosed |
| WO-2023194363-A1 | METAL-ORGANIC COORDINATION COMPOUND COMPRISING CERIUM(III) | BEEOLED GMBH (DE) | 2023-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122228-A1 | METAL-ORGANIC COORDINATION COMPOUND COMPRISING CERIUM(III) | ORC3, MNS1, OCIAD1 | CXCR4 818/4885MEN1 400/4885CHRM2 1190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.